Mblue Labs Secures U.S. Patent for Methylene Blue as a Revolutionary UV Blocker

Bethesda, Maryland — Mblue Labs, renowned for its innovative skincare brand Bluelene, has been awarded a U.S. Patent for its groundbreaking discovery that Methylene Blue acts as a multifunctional UV blocking agent. This remarkable innovation not only shields skin from harmful sun radiation but also slows down skin aging and supports DNA damage repair.

Breakthrough Research Backed by NSF Grant

The journey toward this pivotal discovery began in 2020, supported by a Small Business Technology Transfer (STTR) grant from the National Science Foundation (NSF). The objective was clear: to create a safer and more effective alternative to conventional UV filters like Oxybenzone. This common ingredient, found in over 70% of sunscreens, has faced increasing bans due to potential health risks and environmental harm, particularly in marine ecosystems.

The Power of Methylene Blue

Key Benefits:

• Broad-Spectrum Protection: Guards against both UVA and UVB rays.
• Free Radical Neutralization: Effectively neutralizes reactive oxygen species (ROS).
• DNA Repair: Assists in the repair of DNA damage caused by UV exposure.
• Coral Reef Safety: Environmentally friendly, making it safe for coral ecosystems.

The research findings, published in Nature’s Scientific Reports, underscore Methylene Blue’s potential as a groundbreaking alternative in sun protection.

Expert Insight

Dr. Kan Cao, Professor at the University of Maryland and Founder of Mblue Labs, commented on the patent:

"This patent validates our commitment to redefining sun care with smart, effective, and planet-safe science. Our formula goes beyond surface protection to address the molecular triggers of skin health and aging."

The Launch of Bluevado SunFix

In 2022, Mblue Labs introduced Bluevado SunFix, their first anti-aging sunscreen. This innovative product combines FDA-approved mineral filters, Zinc Oxide and Titanium Dioxide, with Methylene Blue. It has quickly gained a global following among consumers seeking effective, sustainable skincare solutions.

Product Highlights:

• Comprehensive protection against UVB/UVA rays.
• Post-sun recovery benefits.
• Incorporates anti-aging effects of Bluelene Moisturizer.

Jasmin EL Kordi, CEO of Mblue Labs, shared:

"Our Vision for this novel multifunction sunscreen was deeply rooted in our concern for coral reefs and the skin health of our customers."

A Leader in Eco-Friendly Skincare Innovation

The newly acquired patent strengthens Mblue Labs’ growing portfolio in intellectual property, including advances in using Methylene Blue for topical skin applications targeting age-related symptoms.

Bluelene® is rapidly positioning itself as a pioneer in science-based skincare while advocating for environmentally responsible practices.

Future Goals

The company is currently exploring avenues for regulatory approval to include Methylene Blue in the FDA sunscreen monograph, which would broaden access to its beneficial properties for skin and environmental health.

About Mblue Labs and Bluelene

Mblue Labs aims to transform the anti-aging skincare landscape. Their clinical brand, Bluelene, utilizes patented Methylene Blue technology to repair and protect the skin at the mitochondrial level. Research indicates it may even challenge traditional retinol products in anti-aging effectiveness.

For more information on their innovative research and product offerings, visit Mblue Labs or follow them on social media @getbluelene.

Explore the innovative world of skincare where science meets sustainability for effective anti-aging solutions. For any media inquiries or product information, please consult Mblue Labs.